Compare TOVX & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOVX | JXG |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4M | 7.5M |
| IPO Year | 2012 | N/A |
| Metric | TOVX | JXG |
|---|---|---|
| Price | $0.19 | $3.43 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 6.0M | 4.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.77 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.16 | $0.23 |
| 52 Week High | $1.50 | $10.29 |
| Indicator | TOVX | JXG |
|---|---|---|
| Relative Strength Index (RSI) | 46.39 | N/A |
| Support Level | $0.17 | N/A |
| Resistance Level | $0.27 | N/A |
| Average True Range (ATR) | 0.02 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 20.27 | 0.00 |
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.